CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- 4 Open-market buy Director bought 506 shares at $3.30 ($1,670)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $3.34 ($6,680)
- 4 Open-market buy Chief Business Officer bought 2,400 shares at $3.12 ($7,488)
- 4 Open-market buy Chief Business Officer bought 14,949 shares at an average $2.82 ($42,095)
- 4 Open-market buy Chief Executive Officer bought 2,440 shares at $3.12 ($7,615)
- 4 Open-market buy Chief Medical Officer bought 36,000 shares at $2.74 ($98,600)
- 4 Open-market buy Chief Business Officer bought 9,060 shares at an average $2.74 ($24,788)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.85 ($14,250)
- 4 Grant or award 10% owner acquired 1,640,044 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Chief Business Officer bought 223 shares at $3.02 ($673)
- 4 Open-market buy Chief Business Officer bought 736 shares at $3.18 ($2,340)
- 4 Open-market buy Chief Business Officer bought 2,464 shares at an average $3.26 ($8,022)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Business Officer bought 1,900 shares at an average $3.59 ($6,822)
- 4 Open-market buy Chief Business Officer bought 2,500 shares at an average $4.27 ($10,675)
- 4/A Open-market buy Chief Executive Officer bought 1,000 shares at $5.23 ($5,225)
Page 7 of 14 · 266 filings